Navigation Links
Einstein joins the New York Genome Center as 12th institutional founding member
Date:4/11/2013

April 11, 2013 (BRONX, NY) Albert Einstein College of Medicine of Yeshiva University will join the New York Genome Center (NYGC) as its twelfth Institutional Founding Member (IFM). A collaboration among leading academic medical centers, research universities and commercial organizations, NYGC aims to transform medical research and clinical care by creating one of the largest genomics research facilities in North America.

"Einstein is pleased to join other leading biomedical research institutions as a founding member," said Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean. "Working together, we can significantly improve our understanding of genetics and help transform biomedical research with the goal of better understanding disease and improving patient care."

NYGC represents an unprecedented sharing of data and resources among premier institutions, which will pave the way for advances in personalized medicine, accelerate the development of new diagnostics and treatments for human diseases, and provide an engine for life science commercialization in the region.

"Albert Einstein College of Medicine has been involved with the New York Genome Center since its very inception," said Robert B. Darnell, M.D., Ph.D., president & scientific director of NYGC. "We are thrilled to formalize our relationship with this prestigious institution and have its researchers participate in the vibrant life of the center."

NYGC's other IFMs include: Cold Spring Harbor Laboratory, Columbia University, Cornell University/Weill Cornell Medical College, The Jackson Laboratory, Memorial Sloan-Kettering Cancer Center, Mount Sinai Medical Center, NewYork-Presbyterian Hospital, New York University/NYU School of Medicine, North Shore-LIJ Health System, The Rockefeller University, and Stony Brook University.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Feinstein Institute collaborates with GSK, UPenn, MIT to research bodys electrical impulses
2. Einstein study reveals new approach for stopping herpes infections
3. Einstein receives $12 million grant to develop device for preventing HIV infection
4. Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB
5. Feinstein Institute receives $1 million grant to study impact of World Trade Center attacks on responders
6. Einstein hosts its first stem cell institute symposium
7. Einstein researcher receives $10.8 million grant to study toxic blood reactions caused by hemoglobin
8. Denmark joins the Nordic EMBL Partnership for Molecular Medicine
9. Warren Lammert Joins IntelliMedix Board of Advisors
10. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
11. Book shows evolution that joins human and environmental sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Research and Markets has announced the addition of the ... ... The Global Market for Bioproducts Should Reach $714.6 Billion by ... 8.9%, This research report quantifies the two ... segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite materials, ...
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... PARK, Calif., March 23, 2017  BioPharmX Corporation ... products for the dermatology market, today reported financial ... 31, 2017, and will provide an update on ... the year. "We are pleased to ... year for BioPharmX," said President Anja Krammer. "We ...
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
Breaking Biology Technology: